Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Mylan Launches First Generic Version of Generess Fe

April 8, 2015 8:21 am | News | Comments

Mylan has 269 ANDAs pending FDA approval representing $104.1 billion in annual brand sales. Read more...


Analyst: Top Mid-Cap Biotech Companies Increased Revenues to $26.5 Billion in 2014

April 8, 2015 8:21 am | by Adam Dion, Healthcare Industry Analyst, GlobalData | Articles | Comments

The combined total revenues for the peer group of 35 mid-cap biotech companies increased from $24.8 billion in 2013 to $26.5 billion in 2014. Read more...


Tau is the Main Culprit in Alzheimer’s, say Two Studies

April 7, 2015 5:17 pm | by Cynthia Fox, Science Writer | Articles | Comments

Two recent studies have concluded that tau, not amyloid, is the main driver behind Alzheimer’s disease (AD). Read more...


Specialty Drug Prescription Service ZappRx Raises $5.6M

April 7, 2015 2:29 pm | by Ryan Bushey, Associate Editor | Articles | Comments

This brings the total funding for the Boston-based startup to 8.8 million. Read more...


Using Sound Waves to Detect Rare Cancer Cells

April 7, 2015 12:06 pm | by Anne Trafton, MIT | News | Comments

Acoustic device can rapidly isolate circulating tumor cells from patient blood samples. Read more...


Shire: Clear Regulatory Path Forward for Investigational ADHD Treatment

April 7, 2015 11:54 am | News | Comments

Shire plc announces that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on a clear regulatory path for SHP465 (triple-bead mixed amphetamine salts - MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults. Read more..


New R&D Alliance Forms to Find First-Ever Biomarker for Pancreatic Cancer

April 7, 2015 11:49 am | by Ryan Bushey, Associate Editor | Articles | Comments

This program will utilize a precision medicine approach to potentially find a cure for this disease. Read more...


Prosecutors Seek Congressional Probe of Supplement Industry

April 7, 2015 11:48 am | by Mary Esch - Associated Press | News | Comments

Fourteen attorneys general asked Congress to launch an investigation of the herbal supplements industry and to consider giving the U.S. Food and Drug Administration stronger oversight of the industry, New York Attorney General Eric Schneiderman announced. Read more...


Study: Breast Cancer Overtreatment Costs U.S. $4B a Year

April 7, 2015 11:44 am | by Ricardo Alonso-Zaldivar, Associated Press Writer | News | Comments

Sharpening a medical debate about the costs and benefits of cancer screening, a new report estimates that the U.S. spends $4 billion a year on unnecessary medical costs due to mammograms that generate false alarms, and on treatment of certain breast tumors unlikely to cause problems. Read more...


Scientists Identify Receptor for Asthma Associated Virus

April 6, 2015 5:01 pm | by National Institute of Allergy and Infectious Disease | News | Comments

Scientists have identified a cellular receptor for rhinovirus C. Read more...


Cancer Drug Shows Promise for Treating Stroke

April 6, 2015 4:51 pm | by University of Victoria | News | Comments

Neuroscientists discovered a cancer drug may improve recovery rates for diabetic patients who have suffered a stroke. Read more...


BMS, uniQure to Collaborate on Developing Gene Therapies for Cardiovascular Diseases

April 6, 2015 4:42 pm | News | Comments

Bristol-Myers Squibb and uniQure N.V. announced an agreement that provides Bristol-Myers Squibb with exclusive access to uniQure’s gene therapy technology platform for multiple targets in cardiovascular diseases. Read more...


Study Suggests New Role for Gene in Suppressing Cancer

April 6, 2015 4:37 pm | by University of Manchester | News | Comments

Scientists have discovered that a previously known gene also helps cells divide normally and that its absence can cause tumors. Read more...


Two Compounds Target the Gut to Lower Blood Sugar

April 6, 2015 4:32 pm | by Toronto General Hospital Research Institute | News | Comments

Researchers have discovered metformin and resveratrol trigger novel signaling pathways in the small intestine to lower blood sugar. Read more...


Cancer Drug Target also Essential for Blood Cell Recovery

April 6, 2015 4:26 pm | by Walter & Eliza Hall Institute of Medical Research | News | Comments

Blocking key survival proteins is a promising tactic for treating cancer, however new research suggests care should be taken as these proteins are also vital for emergency blood cell production. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.